Inventor · disambiguated record
Christopher Wilson
Also filed as: WILSON CHRISTOPHER · WILSON CHRISTOPHER B · WILSON CHRISTOPHER BRUCE
2 granted patents·7 pending applications·93 citations·filing 1995–2023
58Inventor score
Files withCELLULAR APPROACHES INC3BRISTOL MYERS SQUIBB CO1EDITAS MEDICINE INC1JUNO THERAPEUTICS INC1PRIME MEDICINE INC1
Top patents by PatentIndex Score
9 records- 0187US5993800AMethods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligandBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Nov 30, 1999·93 cites·10 claims
- 0264US2024067940A1Methods and compositions for editing nucleotide sequencesPRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0357US2019201441A1Autologous and allogenic macrophages and monocytes for use in therapeutic methodsCELLULAR APPROACHES INC·Filed 2019·Application pending·0 cites
- 0455US2019076473A1Autologous and allogenic macrophages and monocytes for use in therapeutic methodsCELLULAR APPROACHES INC·Filed 2018·Application pending·0 cites
- 0553US2020289558A1Autologous and allogenic macrophages and monocytes for use in therapeutic methodsCELLULAR APPROACHES INC·Filed 2020·Application pending·0 cites
- 0646US2022184131A1Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0745US12110545B2Methods of assessing nuclease cleavageEDITAS MEDICINE INC·Filed 2018·Granted Oct 8, 2024·0 cites·11 claims
- 0844US2015051210A1Tyrosine Kinase Inhibitor Combinations and their UseTIEDT RALPH·Filed 2013·Application pending·0 cites
- 0939US2016031836A1BiomarkerZHOU WENLAI·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →